Healthcare providers sometimes prescribe antibiotics and other antimicrobials, like antiviral and antifungal medications, to keep people with primary immunodeficiency (PI) from getting infections, instead of to treat infections they already have. This type of treatment is also known as antimicrobial prophylaxis.
Healthcare providers most often prescribe these medicines for people with PI who are either not on immunoglobulin (Ig) replacement therapy or who have breakthrough infections on Ig replacement therapy. Healthcare providers may also prescribe these medicines temporarily for others with PI before they travel, during dental work or surgery, or during cold and flu season.
The goal of antimicrobial prophylaxis is to prevent infections and any problems they cause that could lead to permanent organ damage. The types of germs that tend to cause infections in specific types of PI help healthcare providers decide which antimicrobials to prescribe.
Most of what healthcare providers know about how well prophylactic antimicrobials work for treating PI comes from treating other long-term illnesses, like cystic fibrosis, human immunodeficiency virus (HIV), and chronic obstructive pulmonary disease (COPD).
A survey by the Immune Deficiency Foundation in 2023 found that 18% of patients received prophylactic antimicrobials at some point during their treatment. At the time of the survey, 16% of patients were taking prophylactic antibiotics, and 7% were taking prophylactic antifungals. Other studies have reported that up to 50% of PI patients are on prophylactic antibiotics, especially those with antibody deficiencies [2].
One risk is antimicrobial resistance [9]. Antimicrobial resistance means that a particular medicine no longer works for a germ that it used to be effective against. When someone has an infection that is resistant to antimicrobials, it is the germs themselves that ‘resist’ the drug, not the person’s body.
Germs that become resistant to antimicrobials have changed genetically over time so that they are less and less affected by a particular drug or class of drugs. Antimicrobial resistance is basically an evolutionary survival mechanism for germs.
People with PI who are on prophylactic antimicrobials are particularly at risk of developing antimicrobial-resistant infections because all of the bacteria, fungi, and other germs in their body (known as their microbiome) are constantly exposed to these medicines. Non-harmful germs that develop resistance can then pass that resistance on to infection-causing germs, helping them survive. Not only can these drugs become less effective as preventative measures, but resulting infections can be harder to treat.
To prevent antimicrobial resistance, antimicrobials should be used as prescribed, and only an immunologist can determine if prophylactic antimicrobials are appropriate.
Other risks of antimicrobial prophylaxis include side effects like:
Whether probiotics can help with side effects like diarrhea and nausea should be discussed with your immunologist. Ongoing research suggests probiotics can be helpful [12], but factors like age, health, and genetics should be considered, especially for those who are immunocompromised. Since probiotics are live bacteria, it is important to discuss the specific probiotic you are considering and its ingredients with your immunologist.
This page contains general medical and/or legal information that cannot be applied safely to any individual case. Medical and/or legal knowledge and practice can change rapidly. Therefore, this page should not be used as a substitute for professional medical and/or legal advice. Additionally, links to other resources and websites are shared for informational purposes only and should not be considered an endorsement by the Immune Deficiency Foundation.
Adapted from the IDF Patient & Family Handbook for Primary Immunodeficiency Diseases, Sixth Edition.
Copyright ©2019 by Immune Deficiency Foundation, USA
Receive news and helpful resources to your cell phone or inbox. You can change or cancel your subscription at any time.